Profile: Centocor B.V. is a biopharmaceutical industry. We mainly focus on the management of three major diseases. They are cardiovascular disorder, cancer and immunological disorder. Our products are Remicade® and Reopro®. Reopro® is a monoclonal antibody that forms a complex with glycoprotein receptors at the surface of blood platelets. This product blocks these receptors and prevents the platelets from adhering to each other. It also prevents from forming blood clots.